Dystroglycan 1 (DAG1)

Dystroglycan 1 (DAG1) is an essential component of the dystrophin-glycoprotein complex, which connects the extracellular matrix to the intracellular cytoskeleton in muscle cells and other tissues. This complex is critical for maintaining muscle cell membrane integrity. Glycopeptides related to DAG1 are key in various biochemical interactions vital for muscle function and tissue stability. Therapeutically, DAG1 glycopeptides offer potential for treating muscular dystrophies and other muscle degenerative diseases by addressing disruptions in this complex. Additionally, they contribute to the understanding of cellular adhesion and signaling, which can aid in developing treatments for conditions like cancer and fibrosis. Ongoing research into DAG1 and its glycopeptides promises advancements in therapeutic strategies and a deeper understanding of muscle and tissue biology.